| Name | Marks & Spencer Group |
|---|---|
| Epic | MKS |
| Isin | GB0031274896 |
| Index | UK100 UK350 |
| Industry | Personal Care, Drug and Grocery Stores |
| Latest share price | 377.60p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £7,745.01 | Debt ratio | n/a |
| Shares in issue | 2,047.65 | Debt-to-equity ratio | n/a |
| P/E ratio | 9.2 | Assets / equity ratio | n/a |
| Total dividends per share | 1.00p | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 8.01 |
| Dividend cover | n/a | EPS growth | -17 |
| Earning per share | 18.5 | 52-week high / low | 230.20p / 398.20p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2023-11-16 | 2024-01-12 | 1.00p |
| Interim | 2019-11-14 | 2020-01-10 | 3.90p |
| Final | 2019-05-30 | 2019-07-12 | 7.10p |
| Interim | 2018-11-15 | 2019-01-11 | 6.80p |
| Company name | Marks & Spencer Group |
|---|---|
| Address | Waterside House, 35 North Wharf Road, London, United Kingdom, W2 1NW |
| Telephone | +44 (0) 20 7935 4422 |
| Website | http://corporate.marksandspencer.com/ |
| Director | Position |
|---|---|
| Mr Stuart Machin | CEO |
| Mr Archie Norman | Chairman |
| Mr Cheryl Potter | Non-Executive Director |
| Mr Ronan Dunne | Non-Executive Director |
| Ms Katie Bickerstaffe | Joint CEO |
| Mr Andrew Fisher | Senior Independent Director |
| Ms Evelyn Bourke | Independent Non-Executive Director |
| Mr Justin Matthew King | Independent Non-Executive Director |
| Mrs Sapna Sood | Independent Non-Executive Director |
| Ms Fiona Dawson | Independent Non-Executive Director |
| Mrs Tamara Ingram | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 02/04/23 | 02/04/22 | 03/04/21 |
| Intangible asssets and goodwill | 163.1 | 192.5 | 232 |
| Investments and other non-current assets | 767.9 | 810.9 | 825.8 |
| Total non-current assets | 6942.8 | 7261.1 | 7042.2 |
| Inventory / work in progress | 764.4 | 706.1 | 624.6 |
| Trade and other receivables | 280.6 | 217.1 | 209.6 |
| Cash and equivalents | 1067.9 | 1197.9 | 674.4 |
| Other current assets and asset held for resale | 42.1 | 61.2 | 86.6 |
| Total of all assets | 9097.8 | 9443.4 | 8637.4 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 2706.4 | 2370.8 | 2295.8 |
| Long term liabilities | 3576.5 | 4154.7 | 4055.8 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 6282.9 | 6525.5 | 6351.6 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 2814.9 | 2917.9 | 2285.8 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 19.8 | 19.7 | 489.2 |
| Minority interests | 4.4 | 4.2 | 2.8 |
| Retained earnings | 5839.1 | 5897.9 | 5325.2 |
| Share premium account | 910.7 | 910.6 | 910.4 |
| Total equity | 2814.9 | 2917.9 | 2285.8 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 515.1 | 572.2 | -30.7 |
| Pre-tax profit | 475.7 | 391.7 | -209.4 |